Advertisement

Topics

Companies Related to "Study of BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL)" [Most Relevant Company Matches] - Page: 3 RSS

10:48 EDT 22nd March 2019 | BioPortfolio

Here are the most relevant search results for "Study of BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL)" found in our extensive corporate database of over 50,000 company records.

Showing "Study BuEAM Conditioning Autologous Stem Cell Transplantation ASCT" Companies 51–75 of 2,100+

Relevant

RenovaCare, Inc.

RenovaCare, Inc. is developing first-of-their-kind autologous (self-donated) stem cell therapies for the regeneration of human organs. Its initial product under development targets the body’s largest organ, the skin. The company’s flagship technology, the CellMist™ System, uses its patented SkinGun™ to spray a liquid suspension of a patientâ...


Celling Technologies

Celling Technologies, a SpineSmith Partners company, works closely with surgeons, scientists and engineers to research and develop innovative technologies in the emerging field of regenerative medicine. Celling Technologies' product offering focuses on autologous adult stem cell therapy and the devices and services that complement these procedures. www.cellingtechnologies.com

Celprogen Inc.

Celprogen Inc. is a global Stem Cell Research & Therapeutics company which is developing a proprietary portfolio of unique cancer therapeutics products and life science research tools that includes stem cell technologies for regenerative medicine, as well as bio-engineering products for tissue & organ transplants. Headquartered in San Pedro, California, Ce...


C3

Clinical Cell Culture (C3) is a company listed on the Australian Stock Exchange (ASX Code CCE) that was established to commercialise a number of autologous tissue engineered products for autologous cell replacement.C3 is able to provide culture services from laboratories based in Australia and Europe and is expanding their sales, marketing and clinical support programme throughout the world. This ...

Stemedica International S.A.

Founded in Epalinges, Switzerland, in 2008, Stemedica International S.A. is a global biotechnology company that develops therapeutic applications for the treatment and prevention of Alzheimer’s disease and vascular dementia. The company is a subsidiary of Stemedica Cell Technologies, Inc., a global biotechnology company that manufactures adult allogeneic ...

California Stem Cell, Inc.

California Stem Cell, Inc. is a privately held company focused on the manufacture of high-purity human cells for therapeutic development and screening applications. Since its founding in 2005, CSC has developed and has intellectual property surrounding methods for scalable production of human motor neurons, neuronal progenitors, cardiac cells and liver cel...

Medistem Inc

Medistem Inc. is a biotechnology company developing technologies related to adult stem cell extraction, manipulation, and use for treating inflammatory and degenerative diseases. The company's lead product, the endometrial regenerative cell (ERC), is a "universal donor" stem cell being developed for critical limb ischemia and congestive heart failure. Curr...

Stem Cell Labs Incorporated

Management of new cell culture facilities that focus on culturing cells for heart muscle regeneration, embryonic stem cells, biopsied cardiomyocytes and adult myoblasts in co-culture.

Omnia Biologics, Inc.

Omnia offers services in the areas of process development, GMP manufacture, and fill-finish for preclinical and clinical programs for therapeutics that do not have effective or known manufacturing protocols. These include vaccines, autologous therapeutics, new gene therapeutic platforms, and stem cell technologies. The company seeks and has established rel...

Entest BioMedical Inc.

Entest BioMedical Inc. (OTC Bulletin Board: ENTB) is a majority owned subsidiary of Bio-Matrix Scientific Group Inc (OTC Bulletin Board: BMSN). The Company is involved with the development of stem cell therapy treatments for Chronic Obstructive Pulmonary Disease (COPD), immuno-cancer therapies, testing procedures for diabetes, stem cell research applications for diabetes and other illnesses. The C...

Stemedica Cell Technologies Inc.

Stemedica Cell Technologies Inc. is a specialty biopharmaceutical company that is committed to the manufacturing and development of best-in-class, allogeneic, adult stem cells and stem cell factors for use by approved research institutions and hospitals for pre-clinical and clinical (human) trials. The company is a government-licensed manufacturer of clini...

Cord Blood Registry

Cord Blood Registry® (CBR®) is the world's largest and most experienced stem cell bank. The company's primary focus is enabling parents to preserve the unique population of stem cells from their newborn's umbilical cord and to ensure the viability of the cells for medical use if needed by the child or immediate family member. During the last two decades, CBR has processed and stored cord bloo...

International Stem Cell Institute

About ISCI (www.iStemCelli.com) ISCI is an innovator in providing a pathway to Adipose Stem Cell Therapy and regenerative medicine to restore vibrant health and quality of life for thousands of people with degenerative diseases around the world. The company has a global reach and is dedicated to the highest medical and ethical standards.

Stemedica Cell Technologies, Inc.

Stemedica Cell Technologies, Inc. (www.stemedica.com) is a specialty biopharmaceutical company that is committed to the development and manufacturing of best-in-class adult stem cells and stem cell factors for use by approved research institutions and hospitals for pre-clinical and human clinical trials. The company is currently developing regulatory pathways for stroke and wound repair. Stemedica...

Kiadis Pharma

Kiadis Pharma is an oncology focused biopharmaceutical company developing products that offer novel treatment options for terminally ill cancer patients addressing significant unmet medical needs. The key focus indication for Kiadis Pharma is the limitations and complications of hematopoietic stem cell transplantation procedures.

Cryopraxis

Launched in 2001, Cryopraxis® is Brazil's pioneer company dedicated to long term stem cell banking. Cryopraxis® is also Brazil's leader in research and development with stem cell from bone marrow, cord blood, and adipose tissue.

Antria, Inc.

Antria is a clinical research organization that focuses on the discovery and development of new products and treatments with stem cells derived from adult patients’ own fat cells, known as autologous derived stem cells (ADSCs) to help patients with various chronic and acute medical conditions. Founded in 2010, Antria is based in Indiana, Pennsylvania ...

AmStem Corporation

AmStem Inc. is a corporation registered in the State of Nevada with offices in San Francisco, California and Seoul, Korea. The company is a world leader in the area of stem cell research using stem cells derived from the umbilical cord immediately after birth. The company has 19 U.S. and international patents related to stem cell processing, application an...

The Alliance for the Advancement of Adult Stem Cell Therapy and Research

The Alliance for the Advancement of Adult Stem Cell Therapy and Research, is a non-profit organization dedicated to promoting the use of adult stem cells in the research and treatment of life-altering diseases. This alliance also strives to ensure treatment for those who qualify and could not otherwise afford to receive it. To become a supporting member, p...

Nanopoint Inc.

Nanopoint, Inc. ( www.nanopointimaging.com ) is a privately-held life sciences company that is advancing the study & treatment of diseases with its extended time-lapse live cell imaging solutions. Nanopoint's patented cellTRAY, automated microfluidics delivery system, on-stage incubator and imaging software provides solutions to a broad spectrum of applications including drug discovery, assisted r...

Plasticell

Plasticell is a pioneering biotechnology company that specialises in the differentiation of stem cells to obtain cell types for a range of biomedical applications. Founded in 2002, Plasticell has assembled an outstanding team of scientists with longstanding expertise in stem cell research, particularly in directed stem cell differentiation. The company is advised by an eminent Scientific Advisor...

Stem Cell Innovations

Stem Cell Innovations (SCI) intends to become the global leader in human cell based drug discovery & development. SCI has laboratories and offices in Scotch Plains, N.J., Houston, TX and in Leiden, the Netherlands. SCI's core technology focuses on developing, growing, and manipulating human cells in the laboratory using proprietary technology. By growing pure cultures of individual cell types, SC...

Life Stem Genetics, Inc.

Life Stem Genetics (“LSG”) is a progressive healthcare company focused on Adult Stem Cell (ASC) healing therapies. For decades, stem cells have been utilized in the successful treatment of a variety of ailments. Today, advanced ASC therapies are being offered to patients as an efficient and painless alternative treatment for a wide range of ailme...

PrimeCell Therapeutics LLC

PrimeCell Therapeutics LLC (PCT) is a privately held stem cell engineering company dedicated to optimizing the therapeutic potential of adult stem cells. Our mission is to provide the most potent regenerative cell for use in diverse therapeutic applications and to make these cellular therapies available to potentially every individual. PrimeCell Therapeutics is headquartered in Irvine, California...

Intracel

Intracel is a leading commercial-stage biotechnology company focused on the development of immune therapy to treat cancer. The company’s pipeline includes product development programs in active immunotherapy and fully human monoclonal antibodies. Intracel has completed clinical studies in Colon, Renal and Ovarian carcinoma, as well as Melanoma. Business StrategyRestructured company to focus o...


More From BioPortfolio on "Study of BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL)"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks